THE POTENTIAL COST IMPACT OF USING A PEG HYDROGEL SEALANT TO PREVENT AIR LEAKS AFTER LUNG RESECTION SURGERY IN SPAIN
Author(s)
Ott M1, Larkin M2, Minshall M31Covidien, Zurich, Switzerland, 2PRMA Consulting, Fleet, United Kingdom, 3Covidien, Fishers, IN, USA
OBJECTIVES: Persistent air leaks after lung resection surgery often lead to increased complications including longer length of hospital stay and resulting treatment costs. A PEG hydrogel sealant (PleuraSeal™) is used as an adjunct to standard closure of pleural air leaks during lung resection surgery and has demonstrated shorter hospitalizations (1.7 fewer days; Wain JC et al, 2008, Conference Abstract) and more rapid removal of chest tubes in a clinical study (Covidien, data on file) when compared with standard closure (e.g. staples and sutures alone). Our study was designed to estimate the potential cost offsets for using PleuraSeal™ compared with standard closure in 100 hypothetical patients from a Spanish hospital who had an air leak after lung resection surgery using the cost offset from shorter hospital stays balanced against the cost for PleuraSeal™. METHODS: We assumed the cost for PleuraSeal™ in Spain to be €420 per treatment applied to all 100 hypothetical patients compared with no added cost for standard closure. We then balanced the added cost for PleuraSeal™ with the reduction in number of hospital days and subsequent costs (€590/day [Varela et al, 2006] @1.7 fewer days per patient) compared with standard closure and calculated the potential cost offset for PleuraSeal™. RESULTS: A Spanish hospital that performs 100 lung resections with air leaks can expect to save €58,300, or approximately €583 per patient when compared to standard closure as patients who had air leaks stayed in hospital an average of 1.7 days longer than those without air leaks. CONCLUSIONS: The cost for PleuraSeal™ is completely offset by the shorter length of hospital stay compared with standard closure inSpain. PleuraSeal™ is a compelling option for Spanish hospitals that perform lung resection surgeries as the cost of the treatment is completely offset by the reduction in air leaks and subsequent shorter hospital stay.
Conference/Value in Health Info
2010-11, ISPOR Europe 2010, Prague, Czech Republic
Value in Health, Vol. 13, No. 7 (November 2010)
Code
PRS14
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies, Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Respiratory-Related Disorders